Eevia Health is growing rapidly and has customers in 16 countries and three continents. Turnover was 1.6 M€ in 2019, 2.9 M€ in 2020 and expected to be 7.6 M€ in 2021
Eevia Health employs 22 men and 7 women. It operates a modern manufacturing site in Finland with state-of-the-art green chemistry extraction and purification technologies. The team and a network of external advisors, board members and scientific partners constitute a small life science start-up. Over 4.5 M€ has been invested in equity from 57 shareholders.
|Net sales||3 234||340||2 866|
|Net result of the period||-169||-154||-1 023|
|Earnings per share, EUR*||-0.02||-0.01||-0.10|